Study of blood clots in hospitalized COVID-19 patients
Treatments studied
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study looks at how often blood clot–related problems happen in people hospitalized with serious COVID-19 lung illness. It may help doctors understand risks and improve care for patients in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be hospitalized at Amiens Hospital
- Have a confirmed COVID-19 infection
- Be age 18 or older
- Be able to participate while receiving hospital care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood clot–related complications after COVID-19 (and in some cases flu) in adults admitted to the hospital. It may help doctors better understand and manage these complications.
This study looks at risks of bleeding, blood clots, and blood transfusion needs in patients with COVID-19 who are on a life-support machine called ECMO. If you qualify, the study may help doctors better manage these risks.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study follows patients who have had a blood clot in their leg or lung to learn more about their health over time. It helps doctors understand how to better care for people with blood clots.
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.